GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 51 filers reported holding GLYCOMIMETICS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,438,547 | -14.1% | 1,625,698 | -0.4% | 0.01% | 0.0% |
| Q2 2023 | $2,838,826 | +40.0% | 1,631,509 | +1.4% | 0.01% | +28.6% |
| Q1 2023 | $2,027,417 | +1348.2% | 1,609,061 | +2529.2% | 0.01% | – |
| Q1 2020 | $140,000 | -98.6% | 61,200 | -96.8% | 0.00% | -100.0% |
| Q4 2019 | $10,002,000 | +27.1% | 1,890,492 | +3.5% | 0.02% | +25.0% |
| Q3 2019 | $7,868,000 | -64.5% | 1,825,738 | -1.9% | 0.02% | -62.8% |
| Q2 2019 | $22,184,000 | +92.5% | 1,861,102 | +101.2% | 0.04% | -4.4% |
| Q1 2019 | $11,527,000 | +33.9% | 925,144 | +1.8% | 0.04% | +18.4% |
| Q4 2018 | $8,610,000 | -17.6% | 909,168 | +25.3% | 0.04% | 0.0% |
| Q3 2018 | $10,452,000 | +5.7% | 725,818 | +18.4% | 0.04% | 0.0% |
| Q2 2018 | $9,887,000 | +19.8% | 612,939 | +20.5% | 0.04% | +15.2% |
| Q1 2018 | $8,255,000 | -3.8% | 508,632 | -0.5% | 0.03% | -2.9% |
| Q4 2017 | $8,579,000 | – | 510,974 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,361,801 | $31,729,000 | 3.33% |
| NEA Management Company, LLC | 9,089,041 | $39,174,000 | 3.24% |
| Camber Capital Management LP | 3,500,000 | $15,085,000 | 0.79% |
| Redmile Group, LLC | 1,997,647 | $8,610,000 | 0.29% |
| Alambic Investment Management, L.P. | 41,698 | $180,000 | 0.14% |
| CAXTON CORP | 26,575 | $115,000 | 0.13% |
| PRENTISS SMITH & CO INC | 17,000 | $73,000 | 0.05% |
| Virtus ETF Advisers LLC | 22,580 | $97,000 | 0.02% |
| AXA S.A. | 1,825,738 | $7,868,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 30,000 | $129,000 | 0.01% |